DNA methylation (MCIP-seq) of human acute leukemias and healthy donors
Ontology highlight
ABSTRACT: To measure methylation, we employed Methyl-CpG-immunoprecipitation (MCIP) a technique which relies on a fusion protein consisting of the methyl-binding domain (MBD) of MBD2 and the Fc portion of IgG1 to detect methylated regions, exploiting the natural preference of MBD for 5-methylcytosine (5-mC). MCIP-seq was performed using the EpiMark® Methylated DNA Enrichment Kit. MCIP-seq of 77 primary samples obtained from human acute leukemias, namely AML, T-ALL and mixed myeloid/lymphoid leukemias with CpG Island Methylator Phenotype (CIMP). Moreover, MCIP-seq of CD34+ HSPCs from 3 healthy donors is included. Due to patient confidentiality considerations, the raw data files for this dataset have been deposited to the EGA controlled-access archive under the accession numbers EGAS00001007094 (study); EGAD00001011052 (dataset).
INSTRUMENT(S): Illumina HiSeq 3000
ORGANISM(S): Homo sapiens
SUBMITTER: Ruud Delwel
PROVIDER: E-MTAB-13120 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA